13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE 13D/A Filed 2026-05-20 Event 2026-05-18 SEC 0001193125-26-233062 →

Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics, Inc. IRD

Stake: 4.66% Shares: 3,792,171 CUSIP: 67577R102 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-04-30
DTC 2.16
1,999,457 shares short · +10.7% vs prior

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →